User menu

Tumour hypoxia determines the potential of combining mTOR and autophagy inhibitors to treat mammary tumours

Bibliographic reference Seront, Emmanuel ; Boidot, Romain ; Bouzin, Caroline ; Karroum, Oussama ; Jordan, Bénédicte ; et. al. Tumour hypoxia determines the potential of combining mTOR and autophagy inhibitors to treat mammary tumours. In: The British journal of cancer, Vol. 109, no. 10, p. 2597-2606 (2013)
Permanent URL
  1. Amaravadi R. K., Lippincott-Schwartz J., Yin X.-M., Weiss W. A., Takebe N., Timmer W., DiPaola R. S., Lotze M. T., White E., Principles and Current Strategies for Targeting Autophagy for Cancer Treatment, 10.1158/1078-0432.ccr-10-2634
  2. Amaravadi Ravi K., Yu Duonan, Lum Julian J., Bui Thi, Christophorou Maria A., Evan Gerard I., Thomas-Tikhonenko Andrei, Thompson Craig B., Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma, 10.1172/jci28833
  3. Andre Fabrice, Campone Mario, O'Regan Ruth, Manlius Corinne, Massacesi Cristian, Tarek Sahmoud, Mukhopadhyay Pabak, Soria Jean-Charles, Naughton Michael, Hurvitz Sara A., Phase I Study of Everolimus Plus Weekly Paclitaxel and Trastuzumab in Patients With Metastatic Breast Cancer Pretreated With Trastuzumab, 10.1200/jco.2009.27.8549
  4. Baselga José, Semiglazov Vladimir, van Dam Peter, Manikhas Alexey, Bellet Meritxell, Mayordomo José, Campone Mario, Kubista Ernst, Greil Richard, Bianchi Giulia, Steinseifer Jutta, Molloy Betty, Tokaji Erika, Gardner Humphrey, Phillips Penny, Stumm Michael, Lane Heidi A., Dixon J. Michael, Jonat Walter, Rugo Hope S., Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer, 10.1200/jco.2008.18.8391
  5. Bellot G., Garcia-Medina R., Gounon P., Chiche J., Roux D., Pouyssegur J., Mazure N. M., Hypoxia-Induced Autophagy Is Mediated through Hypoxia-Inducible Factor Induction of BNIP3 and BNIP3L via Their BH3 Domains, 10.1128/mcb.00166-09
  6. Bertout Jessica A., Patel Shetal A., Simon M. Celeste, The impact of O2 availability on human cancer, 10.1038/nrc2540
  7. Boidot R., Vegran F., Meulle A., Le Breton A., Dessy C., Sonveaux P., Lizard-Nacol S., Feron O., Regulation of Monocarboxylate Transporter MCT1 Expression by p53 Mediates Inward and Outward Lactate Fluxes in Tumors, 10.1158/0008-5472.can-11-2474
  8. Bouzin Caroline, Feron Olivier, Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery, 10.1016/j.drup.2007.03.001
  9. Bristow Robert G., Hill Richard P., Hypoxia and metabolism: Hypoxia, DNA repair and genetic instability, 10.1038/nrc2344
  10. Chan Stephen, Scheulen Max E., Johnston Stephen, Mross Klaus, Cardoso Fatima, Dittrich Christian, Eiermann Wolfgang, Hess Dagmar, Morant Rudolph, Semiglazov Vladimir, Borner Markus, Salzberg Marc, Ostapenko Valerijus, Illiger Hans-Joachim, Behringer Dirk, Bardy-Bouxin Nathalie, Boni Joseph, Kong Steven, Cincotta Maria, Moore Laurence, Phase II Study of Temsirolimus (CCI-779), a Novel Inhibitor of mTOR, in Heavily Pretreated Patients With Locally Advanced or Metastatic Breast Cancer, 10.1200/jco.2005.66.130
  11. Crokart N, Cancer Res, 65, 7911 (2005)
  12. Dalby Kevin, Tekedereli Ibrahim, Lopez-Berestein Gabriel, Ozpolat Bulent, Targeting the pro-death and pro-survival functions of autophagy as novel therapeutic strategies in cancer, 10.4161/auto.6.3.11625
  13. Dancey Janet, mTOR signaling and drug development in cancer, 10.1038/nrclinonc.2010.21
  14. Easton J B, Houghton P J, mTOR and cancer therapy, 10.1038/sj.onc.1209886
  15. Eng C H, Abraham R T, The autophagy conundrum in cancer: influence of tumorigenic metabolic reprogramming, 10.1038/onc.2011.220
  16. Eskelinen Eeva-Liisa, The dual role of autophagy in cancer, 10.1016/j.coph.2011.03.009
  17. Feron Olivier, Targeting the tumor vascular compartment to improve conventional cancer therapy, 10.1016/
  18. Fleming Gini F., Ma Cynthia X., Huo Dezheng, Sattar Husain, Tretiakova Maria, Lin L., Hahn Olwen M., Olopade F. O., Nanda R., Hoffman Philip C., Naughton M. J., Pluard Timothy, Conzen Suzanne D., Ellis Matthew J., Phase II trial of temsirolimus in patients with metastatic breast cancer, 10.1007/s10549-011-1910-7
  19. Fokas E., Im J. H., Hill S., Yameen S., Stratford M., Beech J., Hackl W., Maira S.-M., Bernhard E. J., McKenna W. G., Muschel R. J., Dual Inhibition of the PI3K/mTOR Pathway Increases Tumor Radiosensitivity by Normalizing Tumor Vasculature, 10.1158/0008-5472.can-11-2263
  20. Harris Adrian L., HYPOXIA — A KEY REGULATORY FACTOR IN TUMOUR GROWTH, 10.1038/nrc704
  21. Hu Y.-L., DeLay M., Jahangiri A., Molinaro A. M., Rose S. D., Carbonell W. S., Aghi M. K., Hypoxia-Induced Autophagy Promotes Tumor Cell Survival and Adaptation to Antiangiogenic Treatment in Glioblastoma, 10.1158/0008-5472.can-11-3831
  22. Janku Filip, McConkey David J., Hong David S., Kurzrock Razelle, Autophagy as a target for anticancer therapy, 10.1038/nrclinonc.2011.71
  23. Mazure Nathalie M, Pouysségur Jacques, Hypoxia-induced autophagy: cell death or cell survival?, 10.1016/
  24. Mehrpour Maryam, Esclatine Audrey, Beau Isabelle, Codogno Patrice, Overview of macroautophagy regulation in mammalian cells, 10.1038/cr.2010.82
  25. Milani Manuela, Harris Adrian L., Targeting tumour hypoxia in breast cancer, 10.1016/j.ejca.2008.09.025
  26. O'Regan Ruth, Hawk Natalyn Nicole, mTOR inhibition in breast cancer: unraveling the complex mechanisms of mTOR signal transduction and its clinical implications in therapy, 10.1517/14728222.2011.575362
  27. Pries Axel R., Höpfner Michael, le Noble Ferdinand, Dewhirst Mark W., Secomb Timothy W., The shunt problem: control of functional shunting in normal and tumour vasculature, 10.1038/nrc2895
  28. Rouschop Kasper M.A., Ramaekers Chantal H.M.A., Schaaf Marco B.E., Keulers Tom G.H., Savelkouls Kim G.M., Lambin Philippe, Koritzinsky Marianne, Wouters Bradly G., Autophagy is required during cycling hypoxia to lower production of reactive oxygen species, 10.1016/j.radonc.2009.06.029
  29. Rouschop Kasper M.A., van den Beucken Twan, Dubois Ludwig, Niessen Hanneke, Bussink Johan, Savelkouls Kim, Keulers Tom, Mujcic Hilda, Landuyt Willy, Voncken Jan Willem, Lambin Philippe, van der Kogel Albert J., Koritzinsky Marianne, Wouters Bradly G., The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5, 10.1172/jci40027
  30. Semenza Gregg L., Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy, 10.1016/
  31. Seront E, Pinto A, Bouzin C, Bertrand L, Machiels J-P, Feron O, PTEN deficiency is associated with reduced sensitivity to mTOR inhibitor in human bladder cancer through the unhampered feedback loop driving PI3K/Akt activation, 10.1038/bjc.2013.505
  32. Sonveaux Pierre, Dessy Chantal, Martinive Philippe, Havaux Xavier, Jordan Bénédicte F., Gallez Bernard, Grégoire Vincent, Balligand Jean-Luc, Feron Olivier, Endothelin-1 Is a Critical Mediator of Myogenic Tone in Tumor Arterioles : Implications for Cancer Treatment, 10.1158/0008-5472.can-03-1291
  33. Tabernero Josep, Rojo Federico, Calvo Emiliano, Burris Howard, Judson Ian, Hazell Katharine, Martinelli Erika, Cajal Santiago Ramon y, Jones Suzanne, Vidal Laura, Shand Nicholas, Macarulla Teresa, Ramos Francisco Javier, Dimitrijevic Sasa, Zoellner Ulrike, Tang Pui, Stumm Michael, Lane Heidi A., Lebwohl David, Baselga José, Dose- and Schedule-Dependent Inhibition of the Mammalian Target of Rapamycin Pathway With Everolimus: A Phase I Tumor Pharmacodynamic Study in Patients With Advanced Solid Tumors, 10.1200/jco.2007.14.5482
  34. Thomson Angus W., Turnquist Hēth R., Raimondi Giorgio, Immunoregulatory functions of mTOR inhibition, 10.1038/nri2546
  35. Vaupel P., Hypoxia and Aggressive Tumor Phenotype: Implications for Therapy and Prognosis, 10.1634/theoncologist.13-s3-21
  36. Vaupel Peter, Mayer Arnulf, Briest Susanne, Höckel Michael, Hypoxia in Breast Cancer, Oxygen Transport to Tissue XXVI ISBN:038725062X p.333-342, 10.1007/0-387-26206-7_44
  37. Vegran F., Boidot R., Michiels C., Sonveaux P., Feron O., Lactate Influx through the Endothelial Cell Monocarboxylate Transporter MCT1 Supports an NF- B/IL-8 Pathway that Drives Tumor Angiogenesis, 10.1158/0008-5472.can-10-2828
  38. Workman P, Aboagye E O, Balkwill F, Balmain A, Bruder G, Chaplin D J, Double J A, Everitt J, Farningham D A H, Glennie M J, Kelland L R, Robinson V, Stratford I J, Tozer G M, Watson S, Wedge S R, Eccles S A, Guidelines for the welfare and use of animals in cancer research, 10.1038/sj.bjc.6605642
  39. Wouters Bradly G., Koritzinsky Marianne, Hypoxia signalling through mTOR and the unfolded protein response in cancer, 10.1038/nrc2501
  40. Xue Q., Hopkins B., Perruzzi C., Udayakumar D., Sherris D., Benjamin L. E., Palomid 529, a Novel Small-Molecule Drug, Is a TORC1/TORC2 Inhibitor That Reduces Tumor Growth, Tumor Angiogenesis, and Vascular Permeability, 10.1158/0008-5472.can-08-2058
  41. Yi Heqing, Liang Bing, Jia Jie, Liang Nan, Xu Huiying, Ju Guizhi, Ma Shumei, Liu Xiaodong, Differential roles of miR-199a-5p in radiation-induced autophagy in breast cancer cells, 10.1016/j.febslet.2012.12.027
  42. Zhang Q., Bindokas V., Shen J., Fan H., Hoffman R. M., Xing H. R., Time-Course Imaging of Therapeutic Functional Tumor Vascular Normalization by Antiangiogenic Agents, 10.1158/1535-7163.mct-11-0008